Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2016
Home
2016
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
ASX Market Release – Reinstatement
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Appendix 3Y- Change of Director’s Interest Notice
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Usa Launch of Évolis®
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cleansing Statement – Notice under section 708A(5)(e) of the Corporations Act
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Appendix 3Y – Change of Director’s Interest Notice
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
AGM Presentation by CEO
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Results of Annual General Meeting
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmid Receives 831K R&D Tax Credit
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
CxBladder update
Prev page
1
2
3
4
5
6
